title: Sodium butyrate with UCN-01 has marked antitumour activity against cervical cancer cells.
authors.affiliation: Franche-Comte University, EA 3181, IFR 133, University Hospital, Besançon, France.
authors.forename: Anne-Zélie
authors.initials: AZ
authors.lastname: Decrion-Barthod
authors.forename: Matthieu
authors.initials: M
authors.lastname: Bosset
authors.forename: Marie-Laure
authors.initials: ML
authors.lastname: Plissonnier
authors.forename: Antonio
authors.initials: A
authors.lastname: Marchini
authors.forename: Magalie
authors.initials: M
authors.lastname: Nicolier
authors.forename: Sophie
authors.initials: S
authors.lastname: Launay
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Prétet
authors.forename: Jean
authors.initials: J
authors.lastname: Rommelaere
authors.forename: Christiane
authors.initials: C
authors.lastname: Mougin
mesh_terms: D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D002087:Butyrates / Q000008:administration & dosage / Q000494:pharmacology*; D002453:Cell Cycle / Q000187:drug effects; D048708:Cell Growth Processes / Q000187:drug effects; D045744:Cell Line, Tumor; D005260:Female; D006367:HeLa Cells; D052162:Human papillomavirus 16 / Q000302:isolation & purification; D052161:Human papillomavirus 18 / Q000302:isolation & purification; D006801:Humans; D051379:Mice; D008819:Mice, Nude; D030361:Papillomavirus Infections / Q000473:pathology / Q000821:virology; D019311:Staurosporine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000821:virology; D023041:Xenograft Model Antitumor Assays
chemical_list: D002087:Butyrates; C054852:7-hydroxystaurosporine; D019311:Staurosporine